Literature DB >> 16831524

The transcription factor Egr-1 is a regulator of the human TopBP1 gene.

Christian Usskilat1, Christine Skerka, Hans-Peter Saluz, Frank Hänel.   

Abstract

The human topoisomerase IIbeta binding protein 1 (TopBP1) has been reported to be involved in DNA replication, in DNA damage checkpoints and in apoptosis. Detailed analysis of the TopBP1 promoter revealed that the early growth response protein-1 (Egr-1) induces this promoter. Binding of Egr-1 to the TopBP1 promoter was determined to region -50 to -18 using EMSA and ChIP technology. Furthermore, deletion of the E2F transcription factor binding sites or mutation of the Egr-1 transcription factor binding sites lead to reduced stimulation of the TopBP1 promoter by Egr-1. These data indicate a cooperative regulation of the TopBP1 promoter by Egr-1 and E2F.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831524     DOI: 10.1016/j.gene.2006.05.025

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.

Authors:  Kang Liu; Naresh Bellam; Hui-Yi Lin; Bing Wang; Cecil R Stockard; William E Grizzle; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

2.  Identification of co-occurring transcription factor binding sites from DNA sequence using clustered position weight matrices.

Authors:  Young Min Oh; Jong Kyoung Kim; Seungjin Choi; Joo-Yeon Yoo
Journal:  Nucleic Acids Res       Date:  2011-12-19       Impact factor: 16.971

3.  Expression of TopBP1 in hereditary breast cancer.

Authors:  Ewa Forma; Anna Krzeslak; Magdalena Bernaciak; Hanna Romanowicz-Makowska; Magdalena Brys
Journal:  Mol Biol Rep       Date:  2012-04-28       Impact factor: 2.316

4.  Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.

Authors:  Cinzia Pisani; Georgios Strimpakos; Francesca Gabanella; Maria Grazia Di Certo; Annalisa Onori; Cinzia Severini; Siro Luvisetto; Stefano Farioli-Vecchioli; Irene Carrozzo; Antonio Esposito; Tamara Canu; Elisabetta Mattei; Nicoletta Corbi; Claudio Passananti
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-01-31       Impact factor: 5.187

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.